Drugs as CYP3A Probes, Inducers, and Inhibitors
- 1 January 2007
- journal article
- research article
- Published by Taylor & Francis in Drug Metabolism Reviews
- Vol. 39 (4) , 699-721
Abstract
Human cytochrome P450 (CYP) 3A subfamily members (mainly CYP3A4 and CYP3A5) mediate the metabolism of approximately half all marketed drugs and thus play a critical role in the drug metabolism. A huge number of studies on CYP3A-mediated drug metabolism in humans have demonstrated that CYP3A activity exhibits marked ethnic and individual variability, in part because of altered levels of CYP3A4 expression by various environmental factors and functionally important polymorphisms present in CYP3A5 gene. Accumulating evidence has revealed that CYP3A4 and CYP3A5 have a significant overlapping in their substrate specificity, inducers and inhibitors. Therefore, it is difficult to define their respective contribution to drug metabolism and drug-drug interactions. Furthermore, P-glycoprotein and CYP3A are frequently co-expressed in the same cells and share a large number of substrates and modulators. The disposition of such drugs is thus affected by both metabolism and transport. In this review, we systematically summarized the frequently used CYP3A probe drugs, inducers and inhibitors, and evaluated their current status in drug development and research.Keywords
This publication has 126 references indexed in Scilit:
- Effects of dexamethasone on mRNA abundance of nuclear receptors and hepatic nuclear receptor target genes in neonatal calvesJournal of Animal Physiology and Animal Nutrition, 2006
- Phenobarbital regulates nuclear expression of HNF-4α in mouse and rat hepatocytes independent of CAR and PXRHepatology, 2006
- MDR- and CYP3A4-mediated drug–herbal interactionsLife Sciences, 2006
- In vitro and in vivo assessment of herb drug interactionsLife Sciences, 2006
- CYP3A4 activity in four different animal species liver microsomes using 7-benzyloxyquinoline and HPLC/spectrofluorometric determinationJournal of Pharmaceutical and Biomedical Analysis, 2006
- CYP3A Probes Can Quantitatively Predict the In Vivo Kinetics of Other CYP3A Substrates and Can Accurately Assess CYP3A Induction and InhibitionMolecular Interventions, 2005
- METABOLISM OF ALFENTANIL BY CYTOCHROME P4503A (CYP3A) ENZYMESDrug Metabolism and Disposition, 2005
- Expression and induction of CYP3As in human fetal hepatocytesBiochemical and Biophysical Research Communications, 2004
- Regulation of CYP3A5 by Glucocorticoids and Cigarette Smoke in Human Lung-Derived CellsThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Aggravation of vincristine-induced neurotoxicity by itraconazole in the treatment of adult ALLAnnals of Hematology, 1995